Does CANNABIDIOL Cause Product distribution issue? 87 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 87 reports of Product distribution issue have been filed in association with CANNABIDIOL (Epidiolex). This represents 0.5% of all adverse event reports for CANNABIDIOL.
87
Reports of Product distribution issue with CANNABIDIOL
0.5%
of all CANNABIDIOL reports
0
Deaths
10
Hospitalizations
How Dangerous Is Product distribution issue From CANNABIDIOL?
Of the 87 reports, 10 (11.5%) required hospitalization.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANNABIDIOL. However, 87 reports have been filed with the FAERS database.
What Other Side Effects Does CANNABIDIOL Cause?
Seizure (4,980)
Hospitalisation (1,840)
Off label use (1,636)
Product use in unapproved indication (1,585)
Diarrhoea (1,356)
Death (1,115)
Somnolence (1,005)
Product dose omission issue (895)
Drug ineffective (859)
Fatigue (715)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
RELUGOLIX (243)
VEDOLIZUMAB (150)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
Which CANNABIDIOL Alternatives Have Lower Product distribution issue Risk?
CANNABIDIOL vs CANNABIDIOL\HERBALS
CANNABIDIOL vs CANNABIS SATIVA FLOWERING TOP
CANNABIDIOL vs CANNABIS SATIVA SUBSP. INDICA TOP
CANNABIDIOL vs CANRENOATE
CANNABIDIOL vs CANRENOIC ACID